253 related articles for article (PubMed ID: 11481260)
1. Rapid ocular angiogenic control via naked DNA delivery to cornea.
Stechschulte SU; Joussen AM; von Recum HA; Poulaki V; Moromizato Y; Yuan J; D'Amato RJ; Kuo C; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1975-9. PubMed ID: 11481260
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.
Philipp W; Speicher L; Humpel C
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2514-22. PubMed ID: 10937562
[TBL] [Abstract][Full Text] [Related]
3. The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy.
Moore JE; McMullen TC; Campbell IL; Rohan R; Kaji Y; Afshari NA; Usui T; Archer DB; Adamis AP
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2905-15. PubMed ID: 12202509
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.
Lai CM; Brankov M; Zaknich T; Lai YK; Shen WY; Constable IJ; Kovesdi I; Rakoczy PE
Hum Gene Ther; 2001 Jul; 12(10):1299-310. PubMed ID: 11440623
[TBL] [Abstract][Full Text] [Related]
5. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.
Amano S; Rohan R; Kuroki M; Tolentino M; Adamis AP
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):18-22. PubMed ID: 9430540
[TBL] [Abstract][Full Text] [Related]
6. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy with adenoviral plasmids or naked DNA of vascular endothelial growth factor and platelet-derived growth factor accelerates healing of duodenal ulcer in rats.
Deng X; Szabo S; Khomenko T; Jadus MR; Yoshida M
J Pharmacol Exp Ther; 2004 Dec; 311(3):982-8. PubMed ID: 15302893
[TBL] [Abstract][Full Text] [Related]
8. Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration.
Honda M; Sakamoto T; Ishibashi T; Inomata H; Ueno H
Gene Ther; 2000 Jun; 7(11):978-85. PubMed ID: 10849558
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
10. rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice.
Davidoff AM; Nathwani AC; Spurbeck WW; Ng CY; Zhou J; Vanin EF
Cancer Res; 2002 Jun; 62(11):3077-83. PubMed ID: 12036917
[TBL] [Abstract][Full Text] [Related]
11. Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis.
Sakamoto T; Ueno H; Sonoda K; Hisatomi T; Shimizu K; Ohashi H; Inomata H
Gene Ther; 2000 Nov; 7(22):1915-24. PubMed ID: 11127579
[TBL] [Abstract][Full Text] [Related]
12. Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy.
Lai YK; Shen WY; Brankov M; Lai CM; Constable IJ; Rakoczy PE
Gene Ther; 2002 Jun; 9(12):804-13. PubMed ID: 12040462
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of rapamycin on corneal neovascularization in vitro and in vivo.
Kwon YS; Hong HS; Kim JC; Shin JS; Son Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):454-60. PubMed ID: 15671269
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.
Catalano A; Romano M; Martinotti S; Procopio A
Oncogene; 2002 Apr; 21(18):2896-900. PubMed ID: 11973650
[TBL] [Abstract][Full Text] [Related]
15. Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia.
Ozaki NK; Beharry KD; Nishihara KC; Akmal Y; Ang JG; Sheikh R; Modanlou HD
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1546-57. PubMed ID: 11980873
[TBL] [Abstract][Full Text] [Related]
16. [The transfection and expression of IL-1ra gene to the rabbit cornea in situ via cation polymer mediation].
Yuan J; Chen JQ; Zhou SY; Liu ZG; Wang ZC; Gu JJ
Zhonghua Yan Ke Za Zhi; 2006 Aug; 42(8):686-93. PubMed ID: 17081438
[TBL] [Abstract][Full Text] [Related]
17. [Modified vascular endothelia growth factor receptor-mediated targeting nonviral gene delivery system and in vivo beta-gal transducing experiment].
Han J; Tian P; Li J
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):378-82. PubMed ID: 11798790
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesis.
Jani PD; Singh N; Jenkins C; Raghava S; Mo Y; Amin S; Kompella UB; Ambati BK
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2030-6. PubMed ID: 17460257
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression.
Yu H; Wu J; Li H; Wang Z; Chen X; Tian Y; Yi M; Ji X; Ma J; Huang Q
Biochem Biophys Res Commun; 2007 Oct; 361(4):946-52. PubMed ID: 17692288
[TBL] [Abstract][Full Text] [Related]
20. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
